Competing causes of death in patients with locoregionally advanced head and neck cancer treated with concomitant boost radiation plus concurrent weekly cisplatin

By Gómez-Millán Jaime  

Clinical and Translational Oncology, Vol. 15, Iss. 4, 2013-04 ,pp. : 321-326

Springer Publishing Company

Access to resources Recommend Favorite

Concomitant radiochemotherapy vs radiotherapy alone in patients with head and neck cancer: A hellenic cooperative oncology group phase III study

By Fountzilas George   Ciuleanu Elisabeta   Dafni Urania   Plataniotis George   Kalogera-Fountzila Anna   Samantas Epaminontas   Athanassiou Eleni   Tzitzikas John   Ciuleanu Tudor   Nikolaou Angelos   Pantelakos Panayiotis   Zaraboukas Thomas   Zamboglou Nikolaos   Daniilidis John   Ghilezan Nicolas  

Medical Oncology, Vol. 21, Iss. 2, 2004-06 ,pp. : 95-107

Humana Press, Inc

Access to resources Recommend Favorite

Phase II Trial of a Simultaneous Radiochemotherapy with Cisplatinum and Paclitaxel in Combination with Hyperfractionated-Accelerated Radiotherapy in Locally Advanced Head and Neck Tumors

By  

Medical Oncology, Vol. 23, Iss. 3, 2006-09 ,pp. : 325-334

Humana Press, Inc

Access to resources Recommend Favorite

Comparative dosimetric evaluation of the simultaneous integrated boost with photon intensity modulation in head and neck cancer patients

By Fogliata A.   Bolsi A.   Cozzi L.   Bernier J.  

Radiotherapy and Oncology, Vol. 69, Iss. 3, 2003-12 ,pp. : 267-275

Elsevier

Access to resources Recommend Favorite

A Phase I Trial of Docetaxel Based Induction and Concomitant Chemotherapy in Patients with Locally Advanced Head and Neck Cancer

By Seiwert Tanguy   Cohen Ezra   Haraf Daniel   Stenson Kerstin   Blair Elizabeth   Mauer Ann   Dekker Allison   Vokes Everett  

Cancer Investigation, Vol. 25, Iss. 6, 2007-09 ,pp. : 435-444

Informa Healthcare

Access to resources Recommend Favorite